Samsung Medison has announced the launch of the Samsung Z20 in the USA—a AI-powered ultrasound system designed for advanced obstetrician and gynaecologist (OB/GYN) applications.
A recent press release by the company states that the Z20 introduces innovations aimed at overcoming various diagnostic challenges such as high body mass index (BMI) patients, and operator variability, compounded by staffing shortages which impact exam quality and efficiency.
“The Z20 showcases Samsung’s mission to transform women’s health imaging with breakthrough technology that addresses today’s toughest clinical challenges and delivers the quality care every patient deserves,” said Kyu Tae Yoo, chief executive officer of Samsung Medison. “We are thrilled to introduce the Z20 to the US market, reflecting our substantial investment in artificial intelligence and our commitment to maintaining a rapid pace of innovation.”
A key addition is Live ViewAssistTM, a real-time deep learning tool that enhances precision and simplifies advanced OB exams. Key capabilities include:
- Streamlines advanced OB exams with automatic identification of 39 views, real-time quality evaluation, and extraction with no user interaction.
- Automatically labels up to 47 anatomic structures and performs 46 essential measurements.
- Reduces keystrokes by up to 94%1, minimising repetitive tasks.
“The Z20 represents a significant technology milestone for both Samsung and the broader ultrasound industry,” said Tracy Bury, USA business leader, Women’s Health Ultrasound. “The Z20 not only highlights Samsung’s remarkable journey from a fast follower to a technology leader, but also reflects our commitment to breaking the iron triangle of healthcare cost, access, and quality by integrating the Z20 with a digital ecosystem for telesonography, reporting, and fleet management.”
